Ligand Enters into OmniAb® Platform License Agreement with Pandion Therapeutics

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. SPY
2. MDT
3. AAPL
4. SPGI
5. USO
6. DELL
7. ENOV
8. AON
9. NIO
10. A

Go back to Ligand Enters into OmniAb® Platform License Agreement with Pandion Therapeutics
LIGAND PHARMA (NASDAQ: LGND) Delayed: 284.27 +0.17 (0.06%)
Previous Close $284.10    52 Week High $139.79 
Open $286.28    52 Week Low $82.07 
Day High $290.41    P/E 661.09 
Day Low $281.99    EPS $0.43 
Volume 185,017